The coalition will build upon Abbott’s decades of experience with virus surveillance by analyzing virus samples for unknown diseases and detecting virus variants, beginning with emerging variants of the novel coronavirus.
Worldwide, Abbott is collecting virus samples and examining them for mutations in the virus’s genetic sequencing. As new variants are discovered, Abbott will ensure its diagnostic tests can detect them.
The coalition has partnered with the Chicago-based Rush University System for Health. It also has partnered with organizations specializing in virus identification, surveillance, sample collection, testing and data analytics in Columbia, Thailand, Senegal, South Africa, Jamaica, Brazil and India.
More articles on digital transformation:
Baptist Health South Florida launches health tech innovation fellowship
Cincinnati Children’s Hospital receives $5M in innovation funding
Walgreens rolls out voicebot to help customers schedule vaccine appointments
